Biotech, Financing

Promethera gains $31.4 million in series C financing

Posted on 26 November 2014

Tags: , ,

Promethera Biosciences announced the completion of its Series C fundraising round. The company has raised €25.33 million ($31.4 million), including €20.33 million in capital.

The financing round is supported by existing Promethera Biosciences investors and two new investors: SFPI-FPIM, the Belgian Federal Holding and Investment Company, and SMS Investments, a Luxemburg based subsidiary office of the German SMS group.

For further deal information visit Current Agreements (subscription required)


Report: Top 50 Big Pharma Partnering and M&A Deal Trends

Report: Top 50 Big Biotech Partnering and M&A Deal Trends

Browse: Complete Current Partnering report catalog


Print Friendly, PDF & Email

Leave a Reply